THOMAS C. RONK (TCR) - Wall Street Hire Report
esynergies.com
Institutional Research…………….………………...
Sector: BioTech, Pharma & Technology
Strong Hire
Recommendation For:
THOMAS C. RONK (TCR)
417 ORCHID AVE. CORONA DEL MAR, CA 92625
PH: 800-715-9999
EMAIL: TRONK@ADELPHIA.NETBACKGROUND
eSynergies (CEO)......................1999-2002
HealthStar (CEO)......................1998-1999Market Stratagems (Analyst) .....1994-2001
Transamerica (Series 7) .............1992-1998
Bison Financial (VP).................1989-1994
Univ. of CA, San Diego.............1986-1990
COVERAGE HISTORYSectorYearBioTech /
Pharma.……………………2002Healthcare................................
1996-1999Technology/Internet ..................
1994-2001M&A
TRANSACTIONS
Nutra Pharma Acquires Bio Ther…$45 MM
eSynergies Acquires Salesmation ...$45 MM
Gatwick Acquires Aim Smart.......$100 MM
Champion Acquires HealthStar…….$8 MM
FUNDRAISING
eSynergies…..……………….…....$11MM
Aim Smart…………………...……S10MM
HealthStar.....................................$10MM
Transamerica……....………...…..$250MM
Bison Financial…….……….……$300MM
Wall Street veteran with 14 years broad experience in: buy-side and sell-side fundamental and technical research, mergers and acquisitions,corporate finance, venture capital, PIPEs, IPOs, asset management, trading, options, syndication, fixed income, SEC filings, corporate accounting,securities law, contract law, bankruptcy code, shareholder communications, strategic partnerships, international affairs, government relations, licensing, manufacturing, sales, distribution and intellectual property.
BioTech / Pharma: Designed and implemented acquisition strategy for Nutra Pharma Corp, a publicly traded biopharma company. Negotiated $45 million acquisition of Bio Therapeutics Inc. in August 2002. Market Cap reached $160 million.
Negotiated acquisition of Receptopharm in Dec. 2003
Technology / Internet: Founded web-based marketing automationcompany, Salesmation and acquired M2 Limited (online translation) and Commerce Switch (B2B exchange). Sold to publicly traded eSynergies, Inc. for $45 million. Became eSynergies CEO, first quarter in office was profitable, acquired Worldwide Xceed Group (billion dollar interactiveagency) and e2 Communications (email marketing service provider).Negotiated 3 Chapter 11 proceedings (purchased one company, sold one company, one still pending). Negotiated Gatwick acquisition of Aim Smart Corporation and subsequent public trading up to $350 million market cap.
Healthcare: Designed and implemented acquisition strategy for Champion Financial. Sales increased from $600,000 to $17 million with acquisition of HealthStar, Inc. Split adjusted stock price reached $25 per share. As CEO of HealthStar, managed 120,000 doctor PPO and sold it to Beyond Benefits.
Airline / Travel: Research on RCG increased market cap from $7MM to $41MM in 4 months. Volume increased by 12MM+ shares, providing financing for acquisition of SunTrips/Vacation Express with $200MM revs.
Research Collaborations: Interviewed by Sue Herrera and Don Dahler on CNBC regarding Internet research. Co-authored articles with Peter Henig of RedHerring, Thom Calandra of CBS MarketWatch and MSNBC.Registered Analyst for Investor’s Business Daily.</html |
